Use of manzamine compounds in anti-cancer therapeutic regimens
申请人:Guzman A. Esther
公开号:US20070203113A1
公开(公告)日:2007-08-30
Manzamine compounds have been discovered to decrease cell dissociation and cell migration associated with the metastatic potential of cancer cells and a restoration of cancer cell susceptibility to agents, such as TRAIL, which can induce apoptosis. Specifically, Manzamine A has a formerly unrecognized utility in both blocking tumor cell invasion and tumor metastasis as well in restoring cancer cell susceptibility to standard chemotherapeutic agents which induce apoptosis and, therefore, has utility in treating cancer.
Use of Manzamine Compounds in Anti-Cancer Therapeutic Regimens
申请人:Guzman Esther A.
公开号:US20120289533A1
公开(公告)日:2012-11-15
Manzamine compounds have been discovered to decrease cell dissociation and cell migration associated with the metastatic potential of cancer cells and a restoration of cancer cell susceptibility to agents, such as TRAIL, which can induce apoptosis. Specifically, Manzamine A has a formerly unrecognized utility in both blocking tumor cell invasion and tumor metastasis as well in restoring cancer cell susceptibility to standard chemotherapeutic agents which induce apoptosis and, therefore, has utility in treating cancer.
US8232266B2
申请人:——
公开号:US8232266B2
公开(公告)日:2012-07-31
Ircinals A and B from the Okinawan marine sponge Ircinia sp.: plausible biogenetic precursors of manzamine alkaloids